Remote Telemonitoring in Chronic Heart Failure Does Not Reduce Healthcare Cost but Improves Quality of Life: Endpoints of the Cardiobbeat Trial

Voeller, Heinz; Bindl, Dominik; Nagels, Klaus; Hofmann, R.; Vettorazzi, Eik; Wegscheider, Karl; Fleck, Eckart; Nagel, Eckhard

doi:10.1016/s0735-1097(17)34061-5

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For Germany, the CardioBBEAT trial investigated the cost-effectiveness of noninvasive telemonitoring as a primary endpoint. No incremental cost-effectiveness with respect to usual care was observed, although an improvement in quality of life in favour of the intervention group was found [ 14 ]. In addition to studies on noninvasive telemedical interventional management, the cost-effectiveness of invasive remote cardiac monitoring was also investigated.…”

Section: Introductionmentioning

confidence: 99%

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial

et al. 2021

View full text Add to dashboard Cite

Background Noninvasive remote patient management (RPM) in patients with heart failure (HF) has been shown to reduce the days lost due to unplanned cardiovascular hospital admissions and all-cause mortality in the Telemedical Interventional Management in Heart Failure II trial (TIM-HF2). The health economic implications of these findings are the focus of the present analyses from the payer perspective. Methods and results A total of 1538 participants of the TIM-HF2 randomized controlled trial were assigned to the RPM and Usual Care group. Health claims data were available for 1450 patients (n = 715 RPM group, n = 735 Usual Care group), which represents 94.3% of the original TIM-HF2 patient population, were linked to primary data from the study documentation and evaluated in terms of the health care cost, total cost (accounting for intervention costs), costs per day alive and out of hospital (DAOH), and cost per quality-adjusted life year (QALY). The average health care costs per patient year amounted to € 14,412 (95% CI 13,284–15,539) in the RPM group and € 17,537 (95% CI 16,179–18,894) in the UC group. RPM led to cost savings of € 3125 per patient year (p = 0.001). After including the intervention costs, a cost saving of € 1758 per patient year remained (p = 0.048). Conclusion The additional noninvasive telemedical interventional management in patients with HF was cost-effective compared to standard care alone, since such intervention was associated with overall cost savings and superior clinical effectiveness. Graphical abstract

show abstract

Section: Introductionmentioning

confidence: 99%

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The data extracted from the articles isolated after the application of exclusion criteria (n=18) are displayed in Table 1 and refer to seventeen different trials (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28). Two of the articles refer to the same trial (short-and long-term analysis), so their data are presented in the same table row.…”

Section: Resultsmentioning

confidence: 99%

The Effect of Telemedicine on Readmissions of Patients with Heart Failure and/or COPD: a Systematic Review

Stergiopoulos,

Elayadi,

Chen

et al. 2024

Preprint

View full text Add to dashboard Cite

Background Hospital readmissions pose a challenge for modern healthcare systems. Our aim was to assess the efficacy of telemedicine incorporating telemonitoring technologies in decreasing hospital readmissions with a focus on specific patient populations particularly prone to rehospitalization: patients with heart failure (HF) and/ or chronic obstructive pulmonary disease (COPD) through a systematic review. Methods Three major electronic databases, including PubMed, Scopus, and ProQuest’s ABI (Abstracted Business Information)/INFORM Global, were searched for trials employing telemedical technologies and quantifying the effect on the readmission rates in the HF and/or COPD populations. Our search was limited to English-language articles published between 2012 and 2022. Results Eighteen scientific articles referencing seventeen different clinical trials were isolated. Most studies were randomized controlled trials and the readmission related outcome most studied was all-cause readmissions followed by HF and acute exacerbation of COPD readmissions. 47% of the studies suggested that telemedicine might decrease the readmission related burden, while most of the remaining studies suggested that telemedicine had a neutral effect on hospital readmissions. Comparative analysis of studies focusing on the COPD or HF populations resulted in the observation of a clearer association in the reduction of the readmission-related burden in patients with COPD compared to patients with HF (83% vs 27%). Data regarding other relevant outcomes often assessed including all-cause mortality emergency department visits, healthcare costs, quality of life, medication adherence and reconciliation were extracted and qualitatively assessed. Conclusion This systematic review highlights the uncertainty surrounding the effectiveness of telemedicine in reducing the readmission rates of high-risk patients with chronic illnesses, with much of the uncertainty linked to the variability of the deliverable of telemedicine. Nonetheless, the fact that almost all trials found that patients receiving telemedicine benefited to some extent and the strong association in the reduction of readmissions in the COPD population are encouraging. Conduction of more high-quality studies is necessary to draw definitive conclusions.

show abstract

Remote Telemonitoring in Chronic Heart Failure Does Not Reduce Healthcare Cost but Improves Quality of Life: Endpoints of the Cardiobbeat Trial

Cited by 2 publications

References 0 publications

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial

The Effect of Telemedicine on Readmissions of Patients with Heart Failure and/or COPD: a Systematic Review

Contact Info

Product

Resources

About